Lymphocyte subsets and assessment of cancer risk in renal transplant recipients

Transplant International

Volumn 15, Issue 8, 2002, Pages 393-396

  Ducloux, Didier ^a   Carron, Pierre Louis ^a   Motte, Gerard ^a   Ab, Abdelfatah ^a   Rebibou, Jean Michel ^a   Bresson Vautrin, Catherine ^a   Tiberghien, Pierre ^b   Saint Hillier, Yves ^a   Chalopin, Jean Marc ^a  

^a HÔPITAL SAINT JACQUES   (France)

^b Blood Transfus Ctr Franche Comte   (France)

Author keywords

Cancer; Immunosuppression; Lymphocyte subsets; Renal transplantation

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CANCER RISK; CARCINOGENESIS; FOLLOW UP; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LYMPHOCYTE SUBPOPULATION; LYMPHOMA; NEOPLASM; PRIORITY JOURNAL; SKIN CANCER; SOLID TUMOR;

ADULT; AGED; ANTIGENS, CD19; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASMS; RISK;

EID: 0036942083     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2002.tb00187.x     Document Type: Article

References (15)

1. Arends MJ, Benton EC, McLaren KM, Stark LA, Hunter JAA, Bird CC (1997) Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy. Br J Cancer 75:722-727
2. Blohme I, Larkö O (1984) Premalignant and malignant skin lesions in renal transplant patients. Transplantation 37:165-167
3. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou JP (1998) Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens. Lancet 351:623-628
4. Ducloux D, Carron PL, Racadot E, Rebibou JM, Bresson-Vautrin C, saint-Hillier Y, Chalopin JM (1998) CD4 lymphocytopenia in long-term renal transplant recipients. Transplant Proc 30:2859-2860
5. Ducloux D, Carron PL, Rebibou JM, Aubin F, Fournier V, Bresson-Vautrin C, Blanc D, Humbert P, Chalopin JM (1998) CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 65:1270-1272
6. Ducloux D, Carron PL, Racadot E, Rebibou JM, Bresson-Vautrin C, saint-Hillier Y, Chalopin JM (1999) T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies. Transpl Int 12:250-253
7. Ellis D, Jaffe R, Green M, Janosky JJ, Lombardozzi-Lane S, Shapiro R, Scantlebury V, Vivas C, Jordan ML (1998) Epstein-Barr virus related disorders in children undergoing renal transplantation with tacrolimus-based immunosuppression. Transplantation 68:997-1001
8. Euvrard S, Pouteil-Noble C, Kanitakis (1992) Successive occurrence of T-cell and B-cell lymphomas after renal transplantation in a patient with multiple cutaneous squamous cell carcinomas. N Engl J Med 327:1924-1925
9. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M (1999) Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 11:530-534
10. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JPA (1995) Risk of neoplasia in renal transplant recipients. Lancet 346:403-406
11. Morris JDH, Eddleston ALWF, Crook T (1995) Viral infection and cancer. Lancet 346:754-759
12. Muller TF, Grebe SO, Neumann MC, Heymanns J, Radsak K, Sprenger H, Lange H (1997) Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 64:1432-1435
13. Penn I (1994) Occurrence of cancers in immunosuppressed organ transplant recipients. In: Terasaki PI, Cecka JM (eds) Clinical transplants. UCLA Tissue Typing Laboratory, Los Angeles, p 99
14. Penn I (1996) Malignant melanoma in organ allograft recipients. Transplantation 61:274-277
15. Williams RC Jr, Koster FT, Kilpatrick KA (1983) Alteration in lymphocyte cell surface markers during various human infections. Am J Med 75:807-811